Cogent Biosciences (COGT) Peer Comparison

$35.04

$0.47 (1.36%)

As on 03-Sep-2026 12:34EDT

Market cap

$6,016 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

13.8

Div. Yield

0 %

Edit

	Cogent Biosciences (COGT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	6,016	16,765	16,261	13,492	11,994
Revenue ($ Mln)	--	2,782	1,054	2,436	670
Net Profit ($ Mln)	-377.18	491.50	755.85	860.62	-319.95
Net Margin (%)	--	17.67	71.69	35.33	-47.79
RoE (%)	-64.54	110.09	--	42.98	-71.14
Price to Earnings	--	35.25	19.00	17.40	--
Price-To-Book	13.76	39.29	9.76	7.42	26.87

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Cogent Biosciences (COGT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	0.00	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	2.33	1,982.07	103.47	85.67	19.14
Gross Profit	-4.62	760.62	588.53	2,236.43	829.45
Operating Expenses	386.76	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-389.09	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-377.18	598.92	101.11	1,035.47	-252.08
Provision for Tax	0.00	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-377.18	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Cogent Biosciences (COGT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	532.39	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	242.86	187.89	384.48	288.55	1,362.63
Current Liabilities	59.30	1,435.43	464.70	361.93	283.35
Total Liabilities	937.61	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	Cogent Biosciences (COGT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	29.73	1,006.90	895.24	1,243.41	440.60
Current Assets	804.82	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	937.61	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	244.26	120.10	449.89	165.93	864.07
Net Current Assets	0.00	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	Cogent Biosciences (COGT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-264.44	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	-399.53	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	878.23	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Cogent Biosciences (COGT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-56.55	53.56	-30.01	32.82	-0.17
ROE (%)	-64.54	110.09	163.18	42.98	-71.14
ROA (%)	-38.24	15.64	26.53	29.32	-16.12
EBIT Margin (%)	--	21.13	5.73	31.04	-0.77
Net Margin (%)	--	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	--	0.00	0.00	0.00	0.00

Growth Ratios

	Cogent Biosciences (COGT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	--	24.67	114.85	9.23	12.22
EBIT Growth (%)	-32.70	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	-32.77	17.50	378.76	42.89	-115.58
EPS Growth (%)	7.28	26.84	353.27	50.42	-73.87
Book Value Growth (%)	128.78	164.02	816.12	-0.70	-13.57

Valuation Ratios

	Cogent Biosciences (COGT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-17.38	36.06	-59.76	15.79	-2,869.63
Price / Book Value	8.99	35.44	-80.42	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-15.78	28.08	-121.54	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Cogent Biosciences (COGT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.00	0.00	0.05	0.00	0.09
Current Ratio	13.57	0.73	2.99	3.46	5.90
Quick Ratio	13.57	0.73	2.32	3.38	5.90
Interest Coverage	-71.84	--	1.62	--	-1.72

Operating Efficiency Ratios

	Cogent Biosciences (COGT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	--	15.88	21.25	13.74	1.28
Asset Turnover	0.00	0.89	0.37	0.83	0.34
Receivable days	--	50.42	85.52	43.48	1.50
Inventory Days	--	--	1,056.70	96.17	--
Payable days	850.73	6.26	331.01	147.97	221.81
Cash Conversion Cycle	--	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly